Expression of Paxillin in Benign and Malignant Salivary Gland Tumors

Statement of the Problem: Paxillin is a major cytoskeletal protein aberrantly deregulated in various human cancers and involved in tumor growth and invasion. However, the clinicopathological and prognostic significance of paxillin in salivary gland tumors (SGTs) is still unclear. Purpose: This stud...

Full description

Bibliographic Details
Main Authors: Azadeh Andisheh–Tadbir, Aysuda Afshari, Mohammad Javad Ashraf
Format: Article
Language:English
Published: Shiraz University of Medical Sciences 2019-11-01
Series:Journal of Dentistry
Subjects:
Online Access:http://dentjods.sums.ac.ir/article_44909_a8d6f42cd7cf804d0e516987b069f610.pdf
id doaj-f8b39adfad6948dfb0f4dfc8fca5e5c1
record_format Article
spelling doaj-f8b39adfad6948dfb0f4dfc8fca5e5c12020-11-25T02:17:59ZengShiraz University of Medical SciencesJournal of Dentistry2345-64852345-64182019-11-01204249254Expression of Paxillin in Benign and Malignant Salivary Gland TumorsAzadeh Andisheh–Tadbir0Aysuda Afshari 1Mohammad Javad Ashraf2Oral and Dental Disease Research Center, Dept. of Oral and Maxillofacial Pathology, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran.Undergraduate Student, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran.Dept. of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.Statement of the Problem: Paxillin is a major cytoskeletal protein aberrantly deregulated in various human cancers and involved in tumor growth and invasion. However, the clinicopathological and prognostic significance of paxillin in salivary gland tumors (SGTs) is still unclear. Purpose: This study was conducted to evaluate the relationship between paxillin expression and clinicopathological features of patients with SGTs. Materials and Method: In this retrospective study, 50 paraffin-embedded tissue samples which were histologically confirmed as benign (pleomorphic adenoma, PA) or malignant (mucoepidermoid carcinoma (MEC), adenoid cystic carcinoma, ACC) SGTs, and 19 specimens from those with normal salivary gland (NSG) as a control group were assessed for paxillin expression using the immunohistochemistry. The paxillin expression in our samples was scored based on the extent and intensity of immunoreactivity and compared with histological type, clinical stage, and distant metastasis. Results: High paxillin expression was identified in 66% of SGTs whereas all patients with NSG showed low expression (p< 0.0001). Although the expression of paxillin in patients with benign and malignant tumors is similar, there is a significant difference between patients with PA, MEC, and ACC with that of the NSG (p< 0.0001). Paxillin expression was not correlated with clinicopathological features of patients Conclusion: High expression of paxillin was observed in tumoral tissues compared with the controls that establish an important role of paxillin in SGTs but its prognostic role was unclear and need further evaluation. http://dentjods.sums.ac.ir/article_44909_a8d6f42cd7cf804d0e516987b069f610.pdfmucoepidermoid carcinoma ● paxillin ● pleomorphic adenoma ● immunohistochemistry
collection DOAJ
language English
format Article
sources DOAJ
author Azadeh Andisheh–Tadbir
Aysuda Afshari
Mohammad Javad Ashraf
spellingShingle Azadeh Andisheh–Tadbir
Aysuda Afshari
Mohammad Javad Ashraf
Expression of Paxillin in Benign and Malignant Salivary Gland Tumors
Journal of Dentistry
mucoepidermoid carcinoma ● paxillin ● pleomorphic adenoma ● immunohistochemistry
author_facet Azadeh Andisheh–Tadbir
Aysuda Afshari
Mohammad Javad Ashraf
author_sort Azadeh Andisheh–Tadbir
title Expression of Paxillin in Benign and Malignant Salivary Gland Tumors
title_short Expression of Paxillin in Benign and Malignant Salivary Gland Tumors
title_full Expression of Paxillin in Benign and Malignant Salivary Gland Tumors
title_fullStr Expression of Paxillin in Benign and Malignant Salivary Gland Tumors
title_full_unstemmed Expression of Paxillin in Benign and Malignant Salivary Gland Tumors
title_sort expression of paxillin in benign and malignant salivary gland tumors
publisher Shiraz University of Medical Sciences
series Journal of Dentistry
issn 2345-6485
2345-6418
publishDate 2019-11-01
description Statement of the Problem: Paxillin is a major cytoskeletal protein aberrantly deregulated in various human cancers and involved in tumor growth and invasion. However, the clinicopathological and prognostic significance of paxillin in salivary gland tumors (SGTs) is still unclear. Purpose: This study was conducted to evaluate the relationship between paxillin expression and clinicopathological features of patients with SGTs. Materials and Method: In this retrospective study, 50 paraffin-embedded tissue samples which were histologically confirmed as benign (pleomorphic adenoma, PA) or malignant (mucoepidermoid carcinoma (MEC), adenoid cystic carcinoma, ACC) SGTs, and 19 specimens from those with normal salivary gland (NSG) as a control group were assessed for paxillin expression using the immunohistochemistry. The paxillin expression in our samples was scored based on the extent and intensity of immunoreactivity and compared with histological type, clinical stage, and distant metastasis. Results: High paxillin expression was identified in 66% of SGTs whereas all patients with NSG showed low expression (p< 0.0001). Although the expression of paxillin in patients with benign and malignant tumors is similar, there is a significant difference between patients with PA, MEC, and ACC with that of the NSG (p< 0.0001). Paxillin expression was not correlated with clinicopathological features of patients Conclusion: High expression of paxillin was observed in tumoral tissues compared with the controls that establish an important role of paxillin in SGTs but its prognostic role was unclear and need further evaluation.
topic mucoepidermoid carcinoma ● paxillin ● pleomorphic adenoma ● immunohistochemistry
url http://dentjods.sums.ac.ir/article_44909_a8d6f42cd7cf804d0e516987b069f610.pdf
work_keys_str_mv AT azadehandishehtadbir expressionofpaxillininbenignandmalignantsalivaryglandtumors
AT aysudaafshari expressionofpaxillininbenignandmalignantsalivaryglandtumors
AT mohammadjavadashraf expressionofpaxillininbenignandmalignantsalivaryglandtumors
_version_ 1724883877919457280